Anastrozole(CAS: 120511-73-1)

Anastrozole is a non-steroidal aromatase inhibitor used primarily in the treatment of hormone receptor-positive breast cancer. Its chemical formula is C18H18F3NO. It is a white to off-white powder, slightly soluble in water, and has a molecular weight of 323.34 g/mol. Anastrozole works by reducing the amount of estrogen produced in the body, making it an important medication in oncology.

Anastrozole is mainly used in the pharmaceutical industry for treating postmenopausal women with hormone receptor-positive breast cancer. It is also utilized in research for studying estrogen-related pathways and in clinical trials for evaluating its efficacy in various cancer therapies. As an aromatase inhibitor, it has applications in hormonal treatments and drug development.

Anastrozole is generally considered safe when used as directed, but it should be handled with care to avoid skin contact and inhalation. It is classified as a Category B drug by the FDA, indicating that animal studies show no risk to the fetus, but there are limited human studies. Safety measures include proper storage and use of personal protective equipment during handling.

Anastrozole should be stored in a cool, dry place away from direct light. It is typically kept in a tightly sealed container at a temperature range of 15–30°C. Proper storage helps maintain its chemical stability and potency. Avoid exposure to moisture and ensure it is stored in a secure location to prevent accidental ingestion or contamination.